Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 1, 2006, Pages 195-200

  Kim, Jun Sang ^a,b   Kim, Jin Man ^a,b   Li, Shengjin ^a   Yoon, Wan Hee ^a   Song, Kyu Sang ^a   Kim, Ki Hwan ^a   Yeo, Seung Gu ^a   Nam, Ji Sook ^a   Cho, Moon June ^a,b  

^a Chungnam National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Downstaging; Epidermal growth factor receptor; Preoperative chemoradiotherapy; Rectal cancer

Indexed keywords

BIOPSY; PARAFFINS; PATIENT MONITORING; REGRESSION ANALYSIS; TUMORS;

DOWNSTAGING; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOHISTOCHEMISTRY; PREOPERATIVE CHEMORADIOTHERAPY; RECTAL CANCER;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; CAPECITABINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE FRACTIONATION; RECTUM CANCER; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33746824624     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.026     Document Type: Article

References (29)

1. Chen E.T., Mohiuddin M., Brodovsky H., et al. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30 (1994) 169-175
2. Minsky B.D., Cohen A.M., Enker W.E., et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37 (1997) 289-295
3. Janjan N.A., Khoo V.S., Abbruzzese J., et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer. The M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44 (1999) 1027-1038
4. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer. Acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 40 (1998) 1067-1075
5. Kim J.S., Kim J.S., Cho M.J., et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54 (2002) 403-408
6. Mohiuddin M., Hayne M., Regine W.F., et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 48 (2000) 1075-1080
7. Theodoropoulos G., Wise W.E., Padmanabhan A., et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (2002) 895-903
8. Crane C.H., Skibber J.M., Birnbaum E.H., et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57 (2003) 84-89
9. Giralt J., Eraso A., Armengol M., et al. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 1460-1465
10. Chang H.J., Jung K.H., Kim D.Y., et al. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma. Hum Pathol 36 (2005) 364-371
11. Salomon D.S., Brandt R., Ciardiello F., et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
12. Kopp R., Rothbauer E., Mueller E., et al. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels. Dis Colon Rectum 46 (2003) 1391-1399
13. Giralt J., de las Heras M., Cerezo L., et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy. a multicenter, retrospective analysis. Radiother Oncol 74 (2005) 101-108
14. Schmidt-Ullrich R.K., Valerie K.C., Chan W., et al. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 29 (1994) 813-819
15. Akimoto T., Hunter N.R., Buchmiller L., et al. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5 (1999) 2884-2890
16. Liang K., Ang K.K., Milas L., et al. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57 (2003) 246-254
17. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73 (1994) 2680-2686
18. Lamoreaux W.T., Myerson R.J., Malyapa R.S., et al. Predictive factors for response of rectal cancer to preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 63 Suppl. 1 (2005) S284-S285
19. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817
20. Hickey K., Grehan D., Reid I.M., et al. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 74 (1994) 1693-1698
21. Grandis J.R., and Tweardy D.J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53 (1993) 3579-3584
22. Schlessinger J., Schreiber A.B., Levi A., et al. Regulation of cell proliferation by epidermal growth factor. CRC Crit Rev Biochem 14 (1983) 93-111
23. Moyer J.D., Barbacci E.G., Iwata K.K., et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 57 (1997) 4838-4848
24. Kersemaekers A.M., Fleuren G.J., Kenter G.G., et al. Oncogene alterations in carcinomas of the uterine cervix. Overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5 (1999) 577-586
25. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
26. Kavanagh B.D., Dent P., Schmidt-Ullrich R.K., et al. Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res 149 (1998) 579-587
27. Dobert N., Kovacs A.F., Menzel C., et al. The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology. Q J Nucl Med Mol Imaging 49 (2005) 253-257
28. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1053-1059
29. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy. Is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666